VEGFA and ovarian carcinoma: In the case of advanced ovarian cancer, the associated ascitic fluid is known to contain immunosuppressive cytokines, such as IL-10,31 TGF-β32,33 and VEGF,33 which could impair the immune-mediated component of OV therapy and/or the effector function of virus-loaded immune cell carriers.